Recurrent Prostate Cancer
Oncology
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
3 drugs in development·3 companies·8 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Recurrent Prostate Cancer?
BioSniper tracks 3 drugs in development for Recurrent Prostate Cancer across 3 companies.
How many clinical trials target Recurrent Prostate Cancer?
There are 8 clinical trials targeting Recurrent Prostate Cancer tracked by BioSniper.
What is the prevalence of Recurrent Prostate Cancer?
The estimated prevalence of Recurrent Prostate Cancer is approximately 256.0 per 100,000 population.
Deep-dive into Recurrent Prostate Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis